SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001213900-20-007608
Filing Date
2020-03-27
Accepted
2020-03-27 11:07:56
Documents
5
Effectiveness Date
2020-03-27

Document Format Files

Seq Description Document Type Size
1 REGISTRATION STATEMENT ea119975-s8_immucellcorp.htm S-8 126051
2 OPINION OF PIERCE ATWOOD LLP, AS TO THE LEGALITY OF THE SECURITIES ea119975ex5_immucellcorp.htm EX-5 9458
3 CONSENT OF RSM US LLP, INDEPENDENT REGISTERED PUBLIC ACCOUNTANTS ea119975ex23-3_immucellcorp.htm EX-23.3 1538
4 GRAPHIC ex5_001.jpg GRAPHIC 31066
5 GRAPHIC ex5_002.jpg GRAPHIC 16794
  Complete submission text file 0001213900-20-007608.txt   204203
Mailing Address 56 EVERGREEN DRIVE PORTLAND ME 04103
Business Address 56 EVERGREEN DR PORTLAND ME 04103 2078782770
IMMUCELL CORP /DE/ (Filer) CIK: 0000811641 (see all company filings)

IRS No.: 010382980 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-237428 | Film No.: 20749098
SIC: 2835 In Vitro & In Vivo Diagnostic Substances